Search research articles
Contact Us
Filters
Showing results (341-350 of 356) with videos related to
Page
of 36
Sort By:
Infectious Diseases and Therapy
|
March 15, 2024
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination
Timothy E Albertson, Caitlin Hansen, Smiti Bihari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 21, 2026
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18‒55 Years Old
Patricia Winokur, Oyeniyi Diya, David Fitz-Patrick, et al.
The New England Journal of Medicine
|
July 19, 2023
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus
Shabir A Madhi, Annaliesa S Anderson, Judith Absalon, et al.
The New England Journal of Medicine
|
May 27, 2021
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
Robert W Frenck, Nicola P Klein, Nicholas Kitchin, et al.
The New England Journal of Medicine
|
December 10, 2020
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P Polack, Stephen J Thomas, Nicholas Kitchin, et al.
The New England Journal of Medicine
|
January 18, 2023
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years
Patricia Winokur, Juleen Gayed, David Fitz-Patrick, et al.
Vaccine
|
December 17, 2009
Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children
Lucy Chai See Lum, Charissa Fay Borja-Tabora, Robert F Breiman, et al.
Journal of the Pediatric Infectious Diseases Society
|
June 11, 2024
Bivalent Omicron BA.4/BA.5 BNT162b2 Vaccine in 6-Month- to <12-Year-Olds
Lawrence D Sher, Justice K Boakye-Appiah, Sungeen Hill, et al.
The New England Journal of Medicine
|
October 16, 2024
RENOIR Trial - RSVpreF Vaccine Efficacy over Two Seasons
Edward E Walsh, Gonzalo Pérez Marc, Ann R Falsey, et al.
The New England Journal of Medicine
|
September 15, 2021
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
Stephen J Thomas, Edson D Moreira, Nicholas Kitchin, et al.
Page
of 36
Search research articles
Search
Showing results (341-350 of 356) with videos related to
Sort By:
Page
of 36
Infectious Diseases and Therapy
|
March 15, 2024
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination
Timothy E Albertson, Caitlin Hansen, Smiti Bihari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 21, 2026
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18‒55 Years Old
Patricia Winokur, Oyeniyi Diya, David Fitz-Patrick, et al.
The New England Journal of Medicine
|
July 19, 2023
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus
Shabir A Madhi, Annaliesa S Anderson, Judith Absalon, et al.
The New England Journal of Medicine
|
May 27, 2021
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
Robert W Frenck, Nicola P Klein, Nicholas Kitchin, et al.
The New England Journal of Medicine
|
December 10, 2020
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P Polack, Stephen J Thomas, Nicholas Kitchin, et al.
The New England Journal of Medicine
|
January 18, 2023
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years
Patricia Winokur, Juleen Gayed, David Fitz-Patrick, et al.
Vaccine
|
December 17, 2009
Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children
Lucy Chai See Lum, Charissa Fay Borja-Tabora, Robert F Breiman, et al.
Journal of the Pediatric Infectious Diseases Society
|
June 11, 2024
Bivalent Omicron BA.4/BA.5 BNT162b2 Vaccine in 6-Month- to <12-Year-Olds
Lawrence D Sher, Justice K Boakye-Appiah, Sungeen Hill, et al.
The New England Journal of Medicine
|
October 16, 2024
RENOIR Trial - RSVpreF Vaccine Efficacy over Two Seasons
Edward E Walsh, Gonzalo Pérez Marc, Ann R Falsey, et al.
The New England Journal of Medicine
|
September 15, 2021
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
Stephen J Thomas, Edson D Moreira, Nicholas Kitchin, et al.
Page
of 36